Kenvue

Update in progress

KVUE (NYSE)

Company RatingNeutral
SectorConsumer Defensive
IndustryHousehold & Personal Products

Kenvue Inc. is a consumer health company with operations across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. It has three segments: Self Care, Skin Health and Beauty, and Essential Health. It offers OTC medicines for cough, cold, allergy, pain, digestive health, smoking cessation, and eye care, plus personal care, vitamins, and digital health services. Brands include Benadryl, Tylenol, Motrin, Aveeno, Neutrogena, Band-AID, Listerine, Benylin, Sudafed, Visine, and many others. Based in Summit, New Jersey, and incorporated in 2022.

Company score

Sentiment: 0.37; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.18; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.31; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.28; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.09; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.14; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive